Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Add-on-LUCAS2™ resuscitation at NEF Innsbruck].

D Schwaiger1, A Zanvettor, A Neumayr

  • 1Universitätsklinik für Anästhesie und Intensivmedizin, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich. daniel.schwaiger@tirol-kliniken.at.

Die Anaesthesiologie
|April 7, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Evaluation of cancelled emergency physician missions and patient handovers in the area of Innsbruck : Retrospective assessment of physician-staffed emergency medical service cancellations and handovers from the emergency physician to the emergency medical service in 2017 and 2018].

Der Anaesthesist·2021
Same author

Kyasanur forest disease: a state-of-the-art review.

QJM : monthly journal of the Association of Physicians·2020
Same author

[Dispatch center focus issue-do you just sound the alarm or do you already advise?]

Notfall & rettungsmedizin·2020
Same author

Notfall & rettungsmedizin·2020
Same author

[Reform of emergency physician training in Austria : Finally up to date?]

Der Anaesthesist·2017
Same author

Prevalence rates of six selected infectious diseases among African migrants and refugees: a systematic review and meta-analysis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same journal

[Feedback conversations in postgraduate medical education : Structured feedback in anesthesiological postgraduate education at the University Medical Center Hamburg-Eppendorf -A pre-post analysis].

Die Anaesthesiologie·2026
Same journal

[International multidisciplinary consensus statement on perioperative fasting in adults].

Die Anaesthesiologie·2026
Same journal

[Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice].

Die Anaesthesiologie·2026
Same journal

Patent foramen ovale, bone cement implantation syndrome and paradoxical embolism : Case study and pathophysiological aspects.

Die Anaesthesiologie·2026
Same journal

[Muscle relaxation 2026-50 years of searching for the ideal relaxant].

Die Anaesthesiologie·2026
Same journal

[Anesthesiological management of adults with major burn injuries].

Die Anaesthesiologie·2026
See all related articles

Mechanical chest compression devices like LUCAS2™ may improve survival rates in cardiac arrest patients, especially with favorable prognostic factors. This technology facilitates high-quality CPR during complex rescue operations and transport.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Resuscitation Science

Background:

  • Manual cardiopulmonary resuscitation (CPR) is the standard for cardiac arrest.
  • Mechanical chest compression devices offer a potential alternative or adjunct to manual CPR.
  • The LUCAS2™ device provides automated chest compressions, aiming for consistent quality.

Purpose of the Study:

  • To analyze the outcomes of patients receiving LUCAS2™ as add-on CPR.
  • To compare LUCAS2™ use with manual CPR alone.
  • To identify factors influencing the use and effectiveness of LUCAS2™.

Main Methods:

  • Retrospective analysis of data from the German Resuscitation Register (GRR) at NEF Innsbruck (2014-2019).
  • Inclusion of patients who received LUCAS2™ as an add-on treatment.
Keywords:
Cardiac arrestEMSMechanical CPRPre-hospitalSurvival

Related Experiment Videos

  • Comparison of outcomes between LUCAS2™ group and manual CPR group.

    • Main Results:

    • LUCAS2™ was used in 18.8% (123/653) of resuscitations.
    • Overall 30-day survival was 16.2%; 1.4% (9/123) survived with LUCAS2™ add-on CPR.
    • LUCAS2™ use was significantly associated with younger patients, public locations, shockable rhythms, observed arrests, and transport situations.

    Conclusions:

    • Add-on LUCAS2™ CPR may increase survival rates, particularly in patients with favorable prognostic factors.
    • The device facilitates high-quality CPR in challenging environments and during transport.
    • Increased admission rates under CPR necessitate timely treatment decisions in the shock room.